Skip to main content
. 2018 Mar 19;2018:1023490. doi: 10.1155/2018/1023490

Figure 3.

Figure 3

Impairment of ADCC against primary CLL cells by kinase inhibitors. The antibody-dependent increase in the percentages of minimal calcein retention was determined in six or seven independent experiments with 3-fold excess of recombinant 26.5 (a) or 1708-LC3E11 (b) effector cells over CLL target cells. Cytotoxicity was compared to controls without antibodies by paired two-tailed t-test. p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.